Choksi Laboratories

Choksi Laboratories EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Choksi Laboratories (526546.BO) as of Oct 21, 2026 is 54.30 M INR. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 112.35 M INR — a change of -51.67% (lower).

EBITDA

54.30 MINR

YoY

-51.67%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Choksi Laboratories is 2026 54.30 M INR. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Choksi Laboratories was 2025 112.35 M INR. It decreases by -51.67% lower compared to the previous year.

The Choksi Laboratories EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2019
72.65 M INR
Jan 1, 2020
11.14 M INR
Jan 1, 2021
41.25 M INR
Jan 1, 2022
89.10 M INR
Jan 1, 2023
124.95 M INR
Jan 1, 2024
102.23 M INR
Jan 1, 2025
112.35 M INR
Jan 1, 2026
54.30 M INR
The Choksi Laboratories EBITDA history
YEAREBITDAYoY
54.30 MINR-51.67%
112.35 MINR+9.90%
102.23 MINR-18.19%
124.95 MINR+40.24%
89.10 MINR+116.00%
41.25 MINR+270.38%
11.14 MINR-84.67%
72.65 MINR+14.69%
63.34 MINR+163.24%
24.06 MINR-2.56%
24.69 MINR+6.93%
23.09 MINR-16.35%
27.61 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Choksi Laboratories Stock analysis

What does Choksi Laboratories do? Choksi Laboratories Ltd. generates revenue through contract laboratory services for pharmaceuticals, food, agricultural products, construction materials, and chemicals, as well as calibration and validation services for test equipment and process equipment. The company provides environment management services, clinical research, consultancy, and assaying and hallmarking to clients requiring regulatory compliance or analytical testing. Its clients include entities needing pharmaceutical analysis, food and beverage analysis, water analysis, and construction material analysis, alongside those seeking instrument calibration, plant shutdown calibration, and consultancy for in-house calibration laboratories. The firm serves segments such as pharmaceutical manufacturers, food producers, agricultural businesses, construction firms, and environmental management organizations through its comprehensive suite of analytical and calibration solutions. The company's revenue streams include contract laboratory services for pharmaceuticals, food, and agricultural products, alongside calibration services for laboratory and on-site equipment, process equipment, and end-user equipment. Clients utilize these services for regulatory compliance, quality assurance, and operational efficiency, with specific demand from pharmaceutical companies requiring drug testing, food manufacturers needing safety analysis, and construction firms requiring material testing. Choksi Laboratories Ltd. also offers consultancy services for setting up in-house calibration laboratories, catering to organizations aiming to streamline their internal quality control processes. Choksi Laboratories Ltd. delivers analytical testing for pharmaceuticals, food, agricultural products, construction materials, and chemicals, with clients including pharmaceutical manufacturers, food producers, and construction firms. Its calibration services target organizations needing instrument validation and process equipment maintenance, while environment management services support businesses focused on environmental compliance. The company’s consultancy services, including training and third-party inspection, further enhance its offerings for clients requiring specialized expertise in regulatory and quality assurance domains. Choksi Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Choksi Laboratories stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Choksi Laboratories is 54.30 M INR in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Choksi Laboratories changed from 112.35 M INR to 54.30 M INR, representing a -51.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Choksi Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Choksi Laboratories historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Choksi Laboratories

All Key Metrics — Choksi Laboratories